LY-487,379

From Self-sufficiency
Jump to: navigation, search
LY-487,379
200px
Systematic (IUPAC) name
N-(4-(2-methoxyphenoxy)phenyl)- N-(2,2,2-trifluoroethylsulfonyl)pyrid- 3-ylmethylamine
Identifiers
ATC code none
PubChem CID 9825084
IUPHAR/BPS 1402
Chemical data
Formula C21H19F3N2O4S
Molar mass 452.446 g/mol[[Script error: No such module "String".]]
Script error: No such module "collapsible list".
Script error: No such module "TemplatePar".Expression error: Unexpected < operator.

LY-487,379 is a drug used in scientific research that acts as a selective positive allosteric modulator for the metabotropic glutamate receptor group II subtype mGluR2.[1] It is used to study the structure and function of this receptor subtype,[2][3] and LY-487,379 along with various other mGluR2/3 agonists and positive modulators are being investigated as possible antipsychotic and anxiolytic drugs.[4][5][6][7]

See also

References

Cite error: Invalid <references> tag; parameter "group" is allowed only.

Use <references />, or <references group="..." />
Stub icon This pharmacology-related article is a stub. You can help ssf by expanding it.
  1. ↑ Johnson, M. P.; Baez, M.; Jagdmann Jr, G. E.; Britton, T. C.; Large, T. H.; Callagaro, D. O.; Tizzano, J. P.; Monn, J. A.; Schoepp, D. D. (2003). "Discovery of Allosteric Potentiators for the Metabotropic Glutamate 2 Receptor:  Synthesis and Subtype Selectivity ofN-(4-(2-Methoxyphenoxy)phenyl)-N-(2,2,2− trifluoroethylsulfonyl)pyrid-3-ylmethylamine". Journal of Medicinal Chemistry. 46 (15): 3189–3192. doi:10.1021/jm034015u. PMID 12852748.  edit
  2. ↑ Schaffhauser, H.; Rowe, B. A.; Morales, S.; Chavez-noriega, L. E.; Yin, R.; Jachec, C.; Rao, S. P.; Bain, G.; Pinkerton, A. B. (2003). "Pharmacological Characterization and Identification of Amino Acids Involved in the Positive Modulation of Metabotropic Glutamate Receptor Subtype 2". Molecular Pharmacology. 64 (4): 798. doi:10.1124/mol.64.4.798. PMID 14500736.  More than one of |author2= and |last2= specified (help); More than one of |author3= and |last3= specified (help); More than one of |author4= and |last4= specified (help); More than one of |author5= and |last5= specified (help); More than one of |author6= and |last6= specified (help); More than one of |author7= and |last7= specified (help); More than one of |author8= and |last8= specified (help); More than one of |author9= and |last9= specified (help); |first10= missing |last10= in Authors list (help)
  3. ↑ Poisik, O. (2005). "Metabotropic glutamate receptor 2 modulates excitatory synaptic transmission in the rat globus pallidus". Neuropharmacology. 49: 57–50. doi:10.1016/j.neuropharm.2005.03.006.  |first2= missing |last2= in Authors list (help); |first3= missing |last3= in Authors list (help); |first4= missing |last4= in Authors list (help); |first5= missing |last5= in Authors list (help); |first6= missing |last6= in Authors list (help); |first7= missing |last7= in Authors list (help)
  4. ↑ Galici, R.; Echemendia, N. G.; Rodriguez, A. L.; Conn, P. J. (2005). "A Selective Allosteric Potentiator of Metabotropic Glutamate (mGlu) 2 Receptors Has Effects Similar to an Orthosteric mGlu2/3 Receptor Agonist in Mouse Models Predictive of Antipsychotic Activity". Journal of Pharmacology and Experimental Therapeutics. 315: 1181. doi:10.1124/jpet.105.091074. 
  5. ↑ Marino; Conn, P. (2006). "Glutamate-based therapeutic approaches: allosteric modulators of metabotropic glutamate receptors". Current opinion in pharmacology. 6 (1): 98–102. doi:10.1016/j.coph.2005.09.006. PMID 16368268.  edit
  6. ↑ Harich; Gross, G.; Bespalov, A. (2007). "Stimulation of the metabotropic glutamate 2/3 receptor attenuates social novelty discrimination deficits induced by neonatal phencyclidine treatment". Psychopharmacology. 192 (4): 511–519. doi:10.1007/s00213-007-0742-y. PMID 17318501.  edit
  7. ↑ PMID 190790739 (PubMed)
    Citation will be completed automatically in a few minutes. Jump the queue or expand by hand
Retrieved from "http://ssf.f15ijp.com/wiki/index.php?title=LY-487,379&oldid=23843"